deltatrials
Terminated PHASE2 INTERVENTIONAL 6-arm NCT02880241

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

An Open Label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose of MMV390048 in Adult Patients With Acute, Uncomplicated Plasmodium Vivax or Falciparum Malaria Monoinfection Over a 35 Day Period

Sponsor: Jimma University

Conditions Malaria
Interventions MMV390048
Updated 13 times since 2017 Last updated: Dec 8, 2021 Started: Oct 20, 2017 Primary completion: Jan 1, 2018 Completion: Sep 24, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to a Medicines for Malaria Venture (MMV) strategic business decision

A PHASE2 clinical study on Malaria, this trial is terminated or withdrawn. The trial is conducted by Jimma University and has accumulated 13 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Feb 2018 · 4 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Oct 2019 · 13 months · monthly snapshot~Oct 2019 – ~May 2020 · 7 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshot~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 8 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2022 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Jan 2021 — Jan 2022 [monthly]

    Terminated PHASE2

    Status: Suspended → Terminated

▶ Show 8 earlier versions

  1. May 2020 — Jan 2021 [monthly]

    Suspended PHASE2

  2. Oct 2019 — May 2020 [monthly]

    Suspended PHASE2

  3. Sep 2018 — Oct 2019 [monthly]

    Suspended PHASE2

  4. Jun 2018 — Sep 2018 [monthly]

    Suspended PHASE2

  5. Feb 2018 — Jun 2018 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  6. Oct 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  7. Jul 2017 — Oct 2017 [monthly]

    Not Yet Recruiting PHASE2

  8. Jan 2017 — Jul 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jimma University
  • Medicines for Malaria Venture
  • University of Gondar
Data source: Medicines for Malaria Venture

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations